These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22646001)

  • 21. [Treatment of prostatic adenoma with concomitant chronic bacterial prostatitis].
    Davidov MI
    Urologiia; 2011; (1):21-8. PubMed ID: 21500490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relationship of postoperative thrombotic-hemorrhagic complications to the local acute inflammatory process in patients with prostatic adenoma].
    Shabad AL; Rumiantsev VB; Kudriavtsev IuV
    Urol Nefrol (Mosk); 1995; (2):30-3. PubMed ID: 7540339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis].
    Shaplygin LV; Sivakov AA
    Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retropubic adenomectomy in patients with a high level of prostate-specific antigen after prostatic biopsy].
    Veliev EI; Kotov SV; Golubtsova EN; Sokolov AE; Bogdanov AB; Avakian AIu
    Urologiia; 2012; (1):59-63. PubMed ID: 22646005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in researches on the relationship between prostatic diseases and erectile dysfunction].
    Zhan JC; Wei AY
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):462-5. PubMed ID: 15999496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prostaglandin E2 in prostatitis and prostatic adenoma].
    Bauer HW; Bach D
    Urol Int; 1986; 41(2):139-44. PubMed ID: 2425472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From benign prostatic hyperplasia to benign chronic prostatopathy.
    Cohen P
    Med Hypotheses; 2010 Apr; 74(4):760. PubMed ID: 20138709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the enzymatic and hemocoagulative changes in experimental induction of prostatic cancer in albino rats].
    Ronzoni G; Pola P; Fianchini A; Maisano A
    Chir Patol Sper; 1968 Feb; 6():Suppl 6:39-45. PubMed ID: 4194260
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic prostatitis, benign prostatic hyperplasia and immunity: the disorders and correction].
    Konoplia AI; Teodorovich OV; Shatokhin MN; Gavriliuk VP; Mavrin MIu
    Urologiia; 2013; (4):99-103. PubMed ID: 24159776
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate specific antigen.
    Brett T
    Aust Fam Physician; 2011 Jul; 40(7):497-500. PubMed ID: 21743854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of prostatilen in treating patients with prostatic diseases].
    Vozianov AF; Gorpinchenko II; Boĭko NI; Drannik GN; Khavinson VKh
    Urol Nefrol (Mosk); 1991; (6):43-6. PubMed ID: 1823683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific red cell adherence test in benign and malignant lesions of the prostate.
    Ghazizadeh M; Kagawa S; Takigawa H; Kurokawa K; Numoto S
    Br J Urol; 1983 Aug; 55(4):405-7. PubMed ID: 6192865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients].
    Rodríguez Duarte C
    Arch Esp Urol; 1991; 44(6):697-700. PubMed ID: 1722962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative characteristics of the immunologic indicators in patients with prostatic adenoma and cancer].
    Savinov VA; Khalezov SP; Sviridova AM
    Urol Nefrol (Mosk); 1983; (2):17-20. PubMed ID: 6190286
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical approach to the prostate: an update.
    Kutikov A; Guzzo TJ; Malkowicz SB
    Radiol Clin North Am; 2006 Sep; 44(5):649-63, vii. PubMed ID: 17030218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
    Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
    J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autoradiographic examination in prostatic diseases].
    Magasi P; Ruszinkó B
    Z Urol Nephrol; 1976 Apr; 69(4):257-60. PubMed ID: 60014
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased serum amylase levels in prostatic diseases.
    Hanafy HM; Gursel EO; Veenema RJ
    Urology; 1973 Apr; 1(4):372-3. PubMed ID: 4129262
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies to prostate specific antigen in patients with benign prostatic hyperplasia.
    Zisman A; Zisman E; Lindner A; Velikanov S; Siegel YI; Mozes E
    J Urol; 1995 Sep; 154(3):1052-5. PubMed ID: 7543596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.